| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMP1102022 |
| P698 | PubMed publication ID | 21428761 |
| P50 | author | JoAnn E. Manson | Q6204013 |
| P2093 | author name string | Steven K Clinton | |
| Susan T Mayne | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1385-1387 | |
| P577 | publication date | 2011-03-23 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Vitamin D and prevention of cancer--ready for prime time? | |
| P478 | volume | 364 |
| Q52898929 | Calcitriol Inhibits Cervical Cancer Cell Proliferation Through Downregulation of HCCR1 Expression. |
| Q42111039 | Combination of lenalidomide with vitamin D3 induces apoptosis in mantle cell lymphoma via demethylation of BIK. |
| Q33697742 | Correlates of 25-hydroxyvitamin D and breast cancer stage in the Women's Healthy Eating and Living Study |
| Q50787295 | Critical assessment of high-circulation print newspaper coverage of the Institute of Medicine report Dietary Reference Intakes for Calcium and Vitamin D. |
| Q35962084 | Dietary supplements and cancer prevention: balancing potential benefits against proven harms |
| Q35331887 | Emerging role of vitamin D in colorectal cancer |
| Q36476938 | Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status? |
| Q35291755 | Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial |
| Q35740351 | Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications |
| Q33687548 | Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial |
| Q41698394 | Loss of the vitamin D receptor in human breast and prostate cancers strongly induces cell apoptosis through downregulation of Wnt/β-catenin signaling. |
| Q87343175 | Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy |
| Q34975075 | Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. |
| Q37501059 | Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study |
| Q34284547 | Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research |
| Q50555866 | Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study. |
| Q36489300 | Reproducibility of serum 25-hydroxyvitamin d and vitamin D-binding protein levels over time in a prospective cohort study of black and white adults |
| Q37559124 | Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease |
| Q34402156 | Sunlight and Vitamin D: A global perspective for health |
| Q90705218 | The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection |
| Q36955934 | The Vitamin D Receptor, Inflammatory Bowel Diseases, and Colon Cancer |
| Q35955890 | The association between vitamin D receptor expression and prolonged overall survival in breast cancer. |
| Q35758374 | The effect of season of operation on the survival of patients with resected non-small cell lung cancer |
| Q34413712 | The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. |
| Q36003426 | The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. |
| Q36075203 | The relationship between vitamin D and chemotherapy-induced toxicity - a pilot study |
| Q35784205 | The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis |
| Q40209720 | Total and Free Circulating Vitamin D and Vitamin D-Binding Protein in Relation to Colorectal Cancer Risk in a Prospective Study of African Americans |
| Q36994032 | Total vitamin D assay comparison of the Roche Diagnostics "Vitamin D total" electrochemiluminescence protein binding assay with the Chromsystems HPLC method in a population with both D2 and D3 forms of vitamin D. |
| Q34053767 | VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells |
| Q30425759 | Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation |
| Q49540054 | Vitamin D deficiency in Saudi Arabians: A reality or simply hype: A meta-analysis (2008-2015). |
| Q56089631 | Vitamin D in the prevention of disease – what evidence do we still need? |
| Q35094837 | Vitamin D metabolism, mechanism of action, and clinical applications |
| Q36414642 | Vitamin D receptor as a master regulator of the c-MYC/MXD1 network |
| Q37706564 | Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway |
| Q38733247 | Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteop |
| Q36069763 | Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance |
| Q37324106 | Vitamin d deficiency: time for inaction? |
| Q37360447 | Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women |
Search more.